William Facteau
Fortune : 16 273 $ au 30/06/2026
Fortune : 16 273 $ au 30/06/2026
William M.
Facteau is President, Chief Executive Officer & Director at Earlens Corp.
since 2013.
Mr. Facteau is Independent Director at BioCardia, Inc. since 2023.
Former roles include President & Chief Executive Officer at Acclarent, Inc. from 2004 to 2011; Director at Autonomic Technologies, Inc., Cliff Viessman, Inc., NeoTract, Inc., Aerin Medical, Inc., PROCEPT BioRobotics Corp., and ExploraMed Development LLC; Manager-Southeast Regional Sales at Abbott Laboratories and Perclose, Inc.; Principal at United States Surgical Corp.
in 1998; GM-Endovascular Division at Abbott Vascular Devices in 2013; and Entrepreneur-in-Residence at NEA Management Co. LLC.
Education includes undergraduate studies at the University of Connecticut.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOCARDIA, INC. 0,23% | 15/10/2025 | 13 123 ( 0,23% ) | 16 273 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| BIOCARDIA, INC. | Directeur/Membre du Conseil | 18/10/2023 |
Earlens Corp.
Earlens Corp. Medical SpecialtiesHealth Technology Develops medical devices including hearing aids | Directeur Général | 01/11/2013 |
| Sociétés | Poste | Fin |
|---|---|---|
United States Surgical Corp.
United States Surgical Corp. Medical SpecialtiesHealth Technology Manufactures wound closure products and surgical devices | Corporate Officer/Principal | 01/01/1998 |
Cliff Viessman, Inc.
Cliff Viessman, Inc. Air Freight/CouriersTransportation Transports dairy products and sweeteners | Directeur/Membre du Conseil | - |
| PROCEPT BIOROBOTICS CORPORATION | Directeur/Membre du Conseil | - |
Aerin Medical, Inc.
Aerin Medical, Inc. Medical SpecialtiesHealth Technology Develops non-invasive medical devices for nasal respiratory problems | Directeur/Membre du Conseil | - |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Private Equity Investor | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 15 |
|---|---|
Abbott Laboratories
Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
United States Surgical Corp.
United States Surgical Corp. Medical SpecialtiesHealth Technology Manufactures wound closure products and surgical devices | Health Technology |
Perclose, Inc.
Perclose, Inc. Medical SpecialtiesHealth Technology Designs, manufactures, and markets medical devices | Health Technology |
Acclarent, Inc.
Acclarent, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical devices | Health Technology |
NeoTract, Inc.
NeoTract, Inc. BiotechnologyHealth Technology Develops surgical devices for urological and gynecological disorders | Health Technology |
Autonomic Technologies, Inc.
Autonomic Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for the treatment of severe headache autonomic disorder | Health Technology |
Earlens Corp.
Earlens Corp. Medical SpecialtiesHealth Technology Develops medical devices including hearing aids | Health Technology |
Aerin Medical, Inc.
Aerin Medical, Inc. Medical SpecialtiesHealth Technology Develops non-invasive medical devices for nasal respiratory problems | Health Technology |
PROCEPT BioRobotics Corp.
PROCEPT BioRobotics Corp. Medical SpecialtiesHealth Technology Develops robotic therapy systems for the treatment of lower urinary tract symptoms | Health Technology |
Abbott Vascular Devices
Abbott Vascular Devices Medical SpecialtiesHealth Technology Develops and manufactures cardiovascular device for people with cardiovascular disease | Health Technology |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates seeks invests in companies located across the globe. The firm targets companies operating in the fields of technology (software & services, systems, consumer & internet, energy), healthcare (biopharms, devices, services). The firm provides financing for seed, early and growth stage capital requirements. | Finance |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cliff Viessman, Inc.
Cliff Viessman, Inc. Air Freight/CouriersTransportation Transports dairy products and sweeteners | Transportation |
ExploraMed Development LLC
ExploraMed Development LLC Investment ManagersFinance ExploraMed Development invests in companies located in the United States. The firm focuses on companies operating in healthcare sector. It provides financing for seed stage transactions. | Finance |
BioCardia, Inc.
BioCardia, Inc. BiotechnologyHealth Technology Develops biotherapeutics for cardiovascular disease | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national